The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:14
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
下载
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [1] QUANTIFICATION OF TUMOR VOLUME CHANGES DURING RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER
    Fox, Jana
    Ford, Eric
    Redmond, Kristin
    Zhou, Jessica
    Wong, John
    Song, Danny Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 341 - 348
  • [2] Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer
    Christian Ostheimer
    Matthias Bache
    Antje Güttler
    Thomas Reese
    Dirk Vordermark
    BMC Cancer, 14
  • [3] Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer
    Ostheimer, Christian
    Bache, Matthias
    Guettler, Antje
    Reese, Thomas
    Vordermark, Dirk
    BMC CANCER, 2014, 14
  • [4] Radical radiotherapy in non-small-cell lung cancer
    Jovanovski, D
    Smickoska, S
    Crvenkova, S
    Stojkovski, I
    2ND BALKAN CONGRESS OF ONCOLOGY, 1999, : 303 - 308
  • [5] Radiotherapy for non-small-cell lung cancer: Relationship between locoregional failure and irradiated volume.
    Fujimoto, N
    Sumi, M
    Ito, Y
    Imai, A
    Kagami, Y
    Sekine, I
    Tamura, T
    Ikeda, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 686S - 686S
  • [6] Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
    Tatekawa, Kotoha
    Iwata, Hiromitsu
    Kawaguchi, Takatsune
    Ishikura, Satoshi
    Baba, Fumiya
    Otsuka, Shinya
    Miyakawa, Akifumi
    Iwana, Maho
    Shibamoto, Yuta
    RADIATION ONCOLOGY, 2014, 9
  • [7] Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
    Kotoha Tatekawa
    Hiromitsu Iwata
    Takatsune Kawaguchi
    Satoshi Ishikura
    Fumiya Baba
    Shinya Otsuka
    Akifumi Miyakawa
    Maho Iwana
    Yuta Shibamoto
    Radiation Oncology, 9
  • [8] Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy
    Lim, Gerald
    Bezjak, Andrea
    Higgins, Jane
    Moseley, Doug
    Hope, Andrew J.
    Sun, Alex
    Cho, John B. C.
    Brade, Anthony M.
    Ma, Clement
    Bissonnette, Jean-Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 531 - 536
  • [9] Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer
    Willner, J
    Baier, K
    Caragiani, E
    Tschammler, A
    Flentje, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 382 - 389
  • [10] Fatal Tumor Lysis Syndrome During Radiotherapy for Non-Small-Cell Lung Cancer
    Noh, Geum Youb
    Choe, Du Hwan
    Kim, Cheol Hyeon
    Lee, Jae Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 6005 - 6006